REQUEST A DEMO
Total
USD $0.00
Search more companies

Vaks Pharma Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Vaks Pharma Private Limited Profile Updated: May 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Vaks Pharma Private Limited is a company based in India, with its head office in Mumbai. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on October 24, 2001. From the latest financial highlights, Vaks Pharma Private Limited reported a net sales revenue increase of 44.68% in 2025. Its total assets grew by 32.71% over the same period. In 2025, Vaks Pharma Private Limited’s net profit margin increased by 0.01%.

Legal Address
F 21, 1St Floor, Kohinoor Mall, Kirol Road, Kurla West,
Mumbai; Maharashtra; Postal Code: 400070

Contact Details: Purchase the Vaks Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Vaks Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Vaks Pharma Private Limited report to view the information.
Incorporation Date:
October 24, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Mitoch Pharma Private Limited
Company Performance
Financial values in the chart are available after Vaks Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
44.68%
Total Operating Revenue
45.5%
Operating Profit
53.8%
EBITDA
80.57%
Net Profit/Loss for the Period
45.12%
Total Assets
32.71%
Total Equity
19.19%
Operating Profit Margin
0.26%
Net Profit Margin
0.01%
Return on Equity (ROE)
2.88%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?